We are live on
!
Find out more
FAF
Fjarde Ap-fonden Portfolio holdings
AUM
$20.9B
1-Year Est. Return
36.93%
This Fund
S&P 500
This Quarter
Est. Return
+25.08%
1 Year Est. Return
+36.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.97B
AUM Growth
+$1.75B
(+28%)
Cap. Flow
+$349M
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
26.82%
Holding
643
New
25
Increased
368
Reduced
201
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$64.9M |
| 2 |
Microsoft
MSFT
|
+$13.9M |
| 3 |
Amazon
AMZN
|
+$11.6M |
| 4 |
AbbVie
ABBV
|
+$9.54M |
| 5 |
Illinois Tool Works
ITW
|
+$8.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$19.6M |
| 2 |
AGN
Allergan plc
AGN
|
+$16.2M |
| 3 |
Eli Lilly
LLY
|
+$13M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$5.8M |
| 5 |
Bank of America
BAC
|
+$3.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.9% |
| 2 | Healthcare | 14.53% |
| 3 | Financials | 12.89% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Communication Services | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Aptiv
APTV
$10.1B
| $8.05M | 0.1% |
103,359
-5,700
| -5% | -$392K |
|
202
Lam Research
LRCX
$398B
| $8.03M | 0.1% |
248,370
+15,040
| +6% | +$410K |
|
203
Analog Devices
ADI
$185B
| $7.95M | 0.1% |
64,847
+2,200
| +4% | +$242K |
|
204
McKesson
MCK
$97.2B
| $7.95M | 0.1% |
51,825
+6,400
| +14% | +$924K |
|
205
HCA Healthcare
HCA
$86.8B
| $7.94M | 0.1% |
81,788
+4,356
| +6% | +$453K |
|
206
PPG Industries
PPG
$26.2B
| $7.92M | 0.1% |
74,663
-3,100
| -4% | -$299K |
|
207
Ametek
AME
$58.2B
| $7.88M | 0.1% |
88,196
+10,900
| +14% | +$914K |
|
208
Capital One
COF
$136B
| $7.84M | 0.1% |
125,277
-22,300
| -15% | -$1.39M |
|
209
Chipotle Mexican Grill
CMG
$42.8B
| $7.84M | 0.1% |
372,450
+10,000
| +3% | +$185K |
|
210
Rockwell Automation
ROK
$49.5B
| $7.83M | 0.1% |
36,761
| – | – |
|
211
Okta
OKTA
$25.7B
| $7.71M | 0.1% |
38,500
+2,200
| +6% | +$374K |
|
|
ALXN
212
DELISTED
Alexion Pharmaceuticals
ALXN
| $7.69M | 0.1% |
68,505
+4,600
| +7% | +$488K |
|
213
Norfolk Southern
NSC
$76.7B
| $7.67M | 0.1% |
43,714
+5,100
| +13% | +$864K |
|
214
Marathon Petroleum
MPC
$91.3B
| $7.58M | 0.1% |
202,647
+12,800
| +7% | +$411K |
|
215
Kimberly-Clark
KMB
$37B
| $7.54M | 0.09% |
53,360
+7,121
| +15% | +$983K |
|
216
Prudential Financial
PRU
$42.9B
| $7.53M | 0.09% |
123,638
+1,700
| +1% | +$99.8K |
|
217
Sysco
SYY
$39.6B
| $7.46M | 0.09% |
136,567
-8,800
| -6% | -$463K |
|
218
Valero Energy
VLO
$88.9B
| $7.43M | 0.09% |
126,247
+1,464
| +1% | +$87.4K |
|
219
Aflac
AFL
$63.7B
| $7.4M | 0.09% |
205,500
-28,900
| -12% | -$1.04M |
|
220
Willis Towers Watson
WTW
$31.5B
| $7.4M | 0.09% |
37,589
-1,131
| -3% | -$217K |
|
221
Baxter International
BAX
$14.7B
| $7.38M | 0.09% |
85,763
+12,500
| +17% | +$1.09M |
|
222
Zimmer Biomet
ZBH
$18.5B
| $7.35M | 0.09% |
63,464
+2,399
| +4% | +$276K |
|
223
Teradyne
TER
$63.1B
| $7.31M | 0.09% |
86,500
-5,600
| -6% | -$375K |
|
224
State Street
STT
$50.9B
| $7.25M | 0.09% |
114,040
+7,700
| +7% | +$465K |
|
225
WEC Energy
WEC
$35.6B
| $7.24M | 0.09% |
82,565
-7,735
| -9% | -$698K |
|
Similar funds
MMH
VARA
SC
CB
MIC
GT
Fjarde Ap-fonden's Q2 2020 Portfolio in Review
As of Q2 2020, Fjarde Ap-fonden held 643 positions worth $7.97B, up 28% from $6.21B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Fjarde Ap-fonden deployed $349M of net new capital in Q2 2020, opening 25 new positions and adding to 368 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 931,000 shares worth $67.3M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was ExxonMobil, an estimated $19.6M trimmed.
- Fjarde Ap-fonden's largest Q2 2020 buy was iShares MSCI USA Value Factor ETF: 931,000 shares worth $67.3M.
- Fjarde Ap-fonden added most to Microsoft in Q2 2020, an estimated $13.9M increase.
- Fjarde Ap-fonden's biggest Q2 2020 reduction was ExxonMobil, cutting an estimated $19.6M.
- Fjarde Ap-fonden fully exited Allergan plc in Q2 2020, selling an estimated $16.2M.
- Fjarde Ap-fonden's ten largest holdings make up 27% of its $7.97B portfolio in Q2 2020.
- Fjarde Ap-fonden opened 25 new positions and closed 37 in Q2 2020.
- Fjarde Ap-fonden's portfolio value rose 28% quarter-over-quarter to $7.97B.
Based on Fjarde Ap-fonden's 13F filing for Q2 2020, filed 13 Aug 2020.